Thematic

Huntington's Disease: the receipts

Every arrow on the Huntington's Disease map answers to a paper trail, and here is the wall of it: 38 articles, quoted and dated, each pinned to the exact claim it backs. Scan the photos, flip to the spreadsheet, then go argue with the map.
uniQure will seek approval for Huntington's disease gene therapy after... drugdiscoverynews.com Jun 19, 2026 Standard 2
uniQure Plans BLA Submission for AMT-130 Gene Therapy in Huntington’s Disease clinicaltrialvanguard.com Jun 18, 2026 Standard 2
FDA opens path for uniQure’s Huntington’s gene therapy filing - European Biotechnology Magazine european-biotechnology.com Jun 18, 2026 Standard 2
UniQure to seek approval of Huntington’s gene therapy after FDA U-turn - Pharmaceutical Technology pharmaceutical-technology.com Jun 18, 2026 Standard 2
UniQure Shares Soar After FDA Reversal on Its Huntington's Therapy Bloomberg Jun 17, 2026 Standard 2
UniQure to seek approval for Huntington's therapy after FDA U-turn, sh... Reuters Jun 17, 2026 Standard 2
UniQure plans Q3 submission for Huntington’s gene therapy after FDA reverses course—again biospace.com Jun 17, 2026 Standard 2
UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency cnbc.com Jun 17, 2026 Standard 2
The Other Shoe Drops: uniQure Shares Plans To Submit Licensing Application With The FDA for AMT-130 – HDBuzz en.hdbuzz.net Jun 17, 2026 Standard 1
UniQure stock surges after FDA U-turn clears path to gene therapy filing fiercebiotech.com Jun 17, 2026 Standard 3
Regulatory U-turn opens door for uniQure to refile BLA for snubbed gen... firstwordpharma.com Jun 17, 2026 Standard 2
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease globenewswire.com Jun 17, 2026 Standard 1
Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval statnews.com Jun 17, 2026 Standard 2
Toxic Clumps in Huntington's Disease May Protect the Brain Too singularityhub.com Jun 5, 2026 Standard 2
Skyhawk reports encouraging 12-month results for oral Huntington’s disease drug SKY-0515 – HDBuzz en.hdbuzz.net Jun 1, 2026 Standard 1
Two Years In: New Long-Term Extension Data from PIVOT-HD for Votoplam – HDBuzz en.hdbuzz.net May 4, 2026 Standard 1
Proteins in tiny cell tunnels may be Huntington’s treatment target huntingtonsdiseasenews.com Mar 24, 2026 Standard 1
FAU Discovery of Tiny Cell ‘Tunnels fau.edu Mar 20, 2026 Standard 2
Unraveling the Connections between TDP-43 and Huntingtin jneurosci.org Mar 11, 2026 Standard 1
Putting it in print: oral drug branaplam lowered huntingtin, but safety concerns halted development – HDBuzz en.hdbuzz.net Feb 12, 2026 Standard 2
A hitch in the stitch reveals why DNA sequence patterns matter in Huntington’s disease   – HDBuzz en.hdbuzz.net Feb 9, 2026 Standard 1
Scientists Are Finally Closing In on a Treatment For Huntington's Disease sciencealert.com Jan 15, 2026 Standard 1
Sequence Variants in Small CAG Repeat Expansions of the HTT Gene and Disease Onset and Progression in Huntington Disease | Neurology neurology.org Dec 19, 2025 Standard 1
ASOs Restore Cognitive Deficits in Huntington Mice | Neurology Today neurologytoday.aan.com Oct 25, 2025 Standard 2
Development of cognitive, motor, metabolic, and mutant huntingtin aggregation in the zQ175 mouse model of Huntington’s disease - Scientific Reports Nature Oct 3, 2025 Standard 2
Huntingtin protein arranges cytoskeletal filaments, offering insight into neurodegeneration medicalxpress.com Oct 1, 2025 Standard 1
Huntington’s disease treated for first time using gene therapy Nature Sep 25, 2025 Standard 1
The First Domino Falls: AMT-130 Gene Therapy Slows Huntington’s in Landmark Trial – HDBuzz en.hdbuzz.net Sep 24, 2025 Standard 2
In a first, a gene therapy seems to slow Huntington disease science.org Sep 24, 2025 Standard 1
SKY-0515 Lowers Huntingtin In People With Huntington’s Disease In Trial Update – HDBuzz en.hdbuzz.net Sep 18, 2025 Standard 1
SKY-0515 Demonstrates Dose-Dependent Reductions in Mutant Huntingtin Protein in Phase 1 Update | NeurologyLive - Clinical Neurology News and Neurology Expert Insights neurologylive.com Sep 18, 2025 Standard 2
Huntington’s: Huntingtin protein function loss plays key role huntingtonsdiseasenews.com Jul 22, 2025 Standard 1
Update on the Phase II GENERATION HD2 study – International Huntington Association huntington-disease.org Apr 17, 2025 Standard 1
Long somatic DNA-repeat expansion drives neurodegeneration in Huntington’s disease cell.com Dec 1, 2024 High trust 1
MSH3, part of the MutSβ heterodimer that is thought to recognize the p... Oxford Academic Jan 1, 2024 High trust 2
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington’s disease mice - PMC ncbi.nlm.nih.gov Jan 1, 2024 High trust 1
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington’s disease - PMC ncbi.nlm.nih.gov Nov 1, 2023 High trust 1
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington’s disease R6/2 mice - PMC ncbi.nlm.nih.gov Jan 1, 2017 High trust 1

How this wall is built. Citations are extracted while the map ingests its feeds, then resolved to their original articles, photos and all, on a daily pass. Trust tiers reflect the source weighting the map itself uses when it scores an edge.